Sobi
A Medicine Development Leader at Sobi owns the clinical development strategy for nephrology programs within the Core Asset Team, overseeing benefit/risk evaluation, pharmacovigilance, and global regulatory approval from proof of concept to market access. The role involves leading cross-functional teams, designing clinical trials, managing integrated project plans, and engaging with internal stakeholders, the CEO, external health authorities, and key opinion leaders to ensure strategic success.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
Sobi didn’t post a salary, so this is our estimate from similar listings.
22% above the average for this role
Global Development Associate Medical Director
AstraZeneca
Medical Director
Pfizer
Director, Global Clinical Physician - Immunology
Bristol Myers Squibb
(Lead/Senior) Medical Director - Neurodegeneration
Roche
Medical Director
Relay Therapeutics
Associate Director, Global Clinical Physician
Bristol Myers Squibb